Apr. 22, 2025 — A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral ...

Inflammation is a key part of the immune system – but is an overactive inflammatory response to blame for your premature ...

Using information from a cell phone provider, searchers concentrated their efforts in waters to the west of Guam Monday as they continued looking for a 58-year-old man whose boat was reported ...

Nuts are high in nutrients and a good source of fiber, protein, potassium, and more. However, eating certain nuts too often ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Amyotrophic lateral sclerosis (ALS) – known as Lou Gehrig’s Disease based on the iconic 1930s New York Yankee baseball player ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

The survey of 2,000 American drivers, split evenly with 500 per generation, revealed that despite younger generations and ...

A new study finds that specific B-cell subsets at diagnosis may help predict remission in early rheumatoid arthritis, ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...